CDNA: Multiplikator P/S CareDx Health

CareDx, Inc (CDNA) is optimizing costs by outsourcing a portion of its laboratory processes and logistics to third-party contractors. The price-to-sales ratio serves as an indicator of market confidence, with the value of 8.40 acting as the target level. The business relies on the diversification of tests for various organs and software, while organic growth is driven by deep partnerships with clinics without the acquisition of third-party assets.

CDNA: Multiplikator P/S CareDx Corp 04.07.2022 - 13.11.2026

CareDx Corp (CDNA) - rincian metrik lan laporan keuangan

- rega pasar lan target rega analis:

Kutipan saham CareDx, Inc.|CDNA - Prakiraan konsensus analis

- informasi kapitalisasi pasar:

Kapitalisasi pasar CareDx Corp|CDNA - Nilai Total Perusahaan

- data ekuitas miturut neraca:

Nilai Akuntansi Saham CareDx|CDNA - Kapitalisasi Buku|Koefisien Nilai Pasar marang Nilai Buku caredx.com|CDNA - Total Aset Perusahaan

- indikator beban kredit lan likuiditas emiten:

- informasi bathi lan kelipatan valuasi:

- rincian pendapatan lan dodolan emiten:

CDNA - Pendapatan lan volume dodolan|Volume dodolan sing dikarepake perusahaan CareDx Corp|CDNA - Multiplikator P/S|Kapitalisasi marang prakiraan pendapatan CareDx Corp

Ringkesan analitik perusahaan:caredx.com, CDNA

Assessing the investment risks of CareDx, Inc (CDNA) requires an analysis of the market capitalization to annual revenue ratio, which allows for the identification of asset overvaluation through deviations from average values. The efficiency of this model, including the costs of express delivery for biological samples, is reflected in the price-to-sales ratio, measuring how much an investor pays per unit of revenue, which helps determine a safe entry point and the probability of a price correction.

Perusahaan pesaing

Kapitalisasi marang pendapatan agilent.com A|Multiplikator P/S DGX (Quest Diagnostics Incorporated)|Multiplikator P/S Illumina Inc ILMN|EXAS - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan RVTY (Revvity Corp)|BIO: Multiplikator P/S|Rega marang dodolan anbio.com (NNNN)|SHC (Sotera Health) - Multiplikator P/S|Rasio kapitalisasi marang pendapatan QDEL (Quidel Corporation)|Kapitalisasi marang pendapatan OPK (OPKO Corp)|Maravai - Rasio kapitalisasi marang pendapatan|Fulgent Genetics, Inc. - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan LAB|Cytek Biosciences - Multiplikator P/S|Koefisien rega marang pendapatan OraSure Technologies, Inc. OSUR|exagen.com (XGN) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan MDXH|LUCD (Lucid Diagnostics Inc.) - Multiplikator P/S|Kapitalisasi marang pendapatan Prenetics Global Ltd (PRE)|Multiplikator P/S IMDX|Kapitalisasi marang pendapatan trinitybiotech.com TRIB|Multiplikator P/S PRPH (ProPhase)|AIMD: Rasio kapitalisasi marang pendapatan|CODX - Rasio rega marang pendapatan|HSCS (heartsciences.com) - Rasio kapitalisasi marang pendapatan|BMRA: Multiplikator P/S|Cardio Diagnostics Holdings (CDIO) - Multiplikator P/S|Rasio rega marang pendapatan Onconetix Corp|Kapitalisasi marang pendapatan Virax Biolabs Corp (VRAX)|Multiplikator P/S BJDX|AWH - Rega marang dodolan|Multiplikator P/S AXDX (Accelerate Diagnostics, Inc.)|CNTG: Rasio kapitalisasi marang pendapatan|Enzo - Multiplikator P/S|FRES - Multiplikator P/S|gtglabs.com (GENE) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan ME|PMD (Psychemedics Corporation) - Multiplikator P/S